Table 1 Characteristics of participants and total respondents
From: Effects of morbidity on smoking cessation: a national smoking cessation program
| Participants (N = 1245) | Total respondents (N = 1500) | p-valuea | |
|---|---|---|---|
| Sex | 0.342 | ||
| Male | 1118 (89.80) | 1330 (88.67) | |
| Female | 127 (10.20) | 170 (11.33) | |
| Age in years | |||
| Mean ± SD | 48.50 ± 12.55 | 48.90 ± 12.58 | 0.416 |
| < 50 | 647 (51.97) | 762 (50.80) | 0.542 |
| ≥ 50 | 598 (48.03) | 738 (49.20) | |
| Income level | 0.921 | ||
| MHI group | 1084 (87.07) | 1238 (86.94) | |
| LI group | 161 (12.93) | 186 (13.06) | |
| Region | 0.689 | ||
| Seoul and metropolitan areas | 642 (51.57) | 762 (50.80) | |
| Non-metropolitan areas | 603 (48.43) | 738 (49.20) | |
| Health care facility type | 0.693 | ||
| Community clinics | 946 (75.98) | 1130 (75.33) | |
| Others | 299 (24.02) | 370 (24.67) | |
| Program completion status | 0.371 | ||
| Incomplete | 767 (61.61) | 949 (63.27) | |
| Complete | 478 (38.39) | 551 (36.73) | |
| Nicotine dependence levelb,c | 0.974 | ||
| Light/moderate | 832 (66.83) | 907 (66.89) | |
| Severe | 413 (33.17) | 449 (33.11) | |
| Duration of smoking, yearsc | 25.91 ± 11.81 | 26.10 ± 11.84 | 0.691 |
| Smoking cessation medicationc | 0.941 | ||
| Varenicline only | 1101 (88.43) | 1307 (87.90) | |
| Bupropion only | 96 (7.71) | 118 (7.94) | |
| NRT only | 13 (1.04) | 19 (1.28) | |
| Others | 35 (2.81) | 43 (2.89) | |
| Duration of smoking cessation (months) | 0.504 | ||
| < 6 | 688 (55.26) | 848 (56.53) | |
| ≥ 6 | 557 (44.74) | 652 (43.47) | |
| Disease | |||
| HTN | 241 (19.36) | 283 (18.87) | 0.745 |
| DM | 154 (12.37) | 170 (11.33) | 0.402 |
| DL | 95 (7.63) | 109 (7.27) | 0.717 |
| No. of CVD | 0.875 | ||
| 0 | 830 (66.67) | 1021 (68.07) | |
| 1 | 345 (27.71) | 401 (26.73) | |
| 2 | 65 (5.22) | 73 (4.87) | |
| 3 | 5 (0.40) | 5 (0.33) | |
| COPD | 64 (5.14) | 71 (4.73) | 0.623 |
| MDD | 45 (3.61) | 49 (3.27) | 0.618 |